Changeflow GovPing Pharma & Drug Safety Psilocybin therapy Indiana University depressio...
Routine Notice Added

Psilocybin therapy Indiana University depression trial

Favicon for clinicaltrials.gov ClinicalTrials.gov
Detected March 31st, 2026
Email

Summary

Psilocybin therapy Indiana University depression trial

View original document View source feed page

Source document (simplified)

Show glossary

Related changes

Favicon for clinicaltrials.gov Anti-alpha-actinin antibodies, lupus nephritis, diagnostic tests study
Routine Apr 02, 2026 • ClinicalTrials.gov • Pharma & Drug Safety
Favicon for clinicaltrials.gov Study comparing peer support vs staff-delivered transportation for young adults with disabilities
Routine Apr 02, 2026 • ClinicalTrials.gov • Pharma & Drug Safety
Favicon for clinicaltrials.gov MucoLock oral gel device clinical trial for stomatitis, burning mouth, pain
Routine Apr 02, 2026 • ClinicalTrials.gov • Pharma & Drug Safety

Source

Favicon for clinicaltrials.gov
ClinicalTrials.gov clinicaltrials.gov/ct2/results/rss.xml
Pharma & Drug Safety
Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
GP
Instrument
Notice

Browse Categories

Agriculture & Food Safety 63 AI Regulation 3 Banking & Finance 266 Consumer & Competition 1 Consumer Protection 44 Courts & Legal 358 Data Privacy & Cybersecurity 74 Defense & National Security 52 Education 20 Energy 107 Environment 85 Government & Legislation 324 Healthcare 136 Housing 16 Immigration 9 Insurance 58 Labor & Employment 113 Legal & Courts 1 Pharma & Drug Safety 103 Securities & Markets 104 Tax 65 Tax & Revenue 1 Telecom & Technology 47 Trade & Sanctions 124 Transportation 57

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ClinicalTrials.gov publishes new changes.

Optional. Personalizes your daily digest.

Free. Unsubscribe anytime.